| |
|
Form Serial Number: |
DA20251030E00042
|
| 1.
Date of relevant event: |
27/10/2025
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02453 |
| 4.
Name of listed corporation: |
Concord Healthcare Group Co., Ltd. |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
313,874,624 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
YANG |
| (Other names) |
Jianyu |
|
|
|
| 10.
Name of director (Chinese): |
杨建宇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1316 | There has been a change in nature of your interest in the shares because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
35,600,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 63,859,100 | 20.35 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 63,859,100 | 20.35 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Morgancreek Investment Holdings Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | YANG Jianyu | 100.00 | N | |
| Concord Medical Services Holdings Limited | Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands; Cayman Islands | Morgancreek Investment Holdings Limited | 73.20 | N | |
| Ascendium Group Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin Islands | Concord Medical Services Holdings Limited | 100.00 | N | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | N | |
| Tianjin Concord Medical Technology Co., Ltd. | K52. 11/F, Door 2, Block D, No. 1 Gonghua Road, Huayuan Industrial Zone, Binhai High Tech Zone, Tianjin, PRC; People's Republic of China | Medstar (Shanghai) Enterprise Management Co., LTD | 100.00 | Y | |
| Concord Hospital Management Group Limited | Room 1701, 9 Chong Yip Street, Kwun Tong, Kowloon, Hong Kong; Hong Kong | Ascendium Group Limited | 100.00 | N | |
| Beijing Concord Medical Technology Co., Ltd. | Room 2702, Block A, No. 36, North Third Ring East Road, Dongcheng District, Beijing, PRC; People's Republic of China | Concord Hospital Management Group Limited | 100.00 | Y | |
| Medstar (Shanghai) Enterprise Management Co., LTD | Room 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of China | Ascendium Group Limited | 98.19 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
On October 27, 2025, Beijing Concord Medical Technology Co., Ltd. (北京泰和誠醫療技術有限公司) was released from the pledge of 35.6 million H shares of the listed corporation which was to secure the listed corporation's obligations under the Credit Line Agreement. Please refer to the announcement of the listed corporation dated August 26 and October 27, 2025.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
30/10/2025
(dd/mm/yyyy)
|
| |